TARDBP and neurodegenerative disease: The use of anti-TDP-43 antibodies have dramatically improved our knowledge about the spectrum of pathological changes underlying FTLD and ALS and it is highly recommended to implement immunohistochemistry for TDP-43 as routine stain in the neuropathological diagnostics of neurodegenerative diseases.